QIAGEN N.V. (QGEN) revenue & profit
QIAGEN N.V. (QGEN): revenue $2.1B, net income $424.9M in 2025; latest quarter – year over year. From SEC filings.
$2.1BRevenue 2025
TickerQGEN (NYSE)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$2.1B
Net income 2025$424.9M
Net margin20.3%
Annual revenue growth+5.7%
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $2.1B | $423.2M | |
| 2023 | $2B | $341.3M | |
| 2024 | $2B | $83.6M | |
| 2025 | $2.1B | $424.9M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.